![]() |
Volumn 41, Issue 3, 2002, Pages 231-238
|
Systemic treatment for metastatic renal cell carcinoma and long-term results;Systematische immuntherapie des metastesierten nierenzellkarzinoms und ihre langzeitergebnisse
|
Author keywords
Immunotherapy; Interferon ; Interleukine 2; Renal cell carcinoma; Treatment
|
Indexed keywords
ALPHA INTERFERON;
FLUOROURACIL;
INTERLEUKIN 2;
ANTINEOPLASTIC AGENT;
ADVANCED CANCER;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CANCER THERAPY;
DRUG CHOICE;
DRUG RESPONSE;
GERMANY;
HUMAN;
KIDNEY CARCINOMA;
METASTASIS;
REVIEW;
SYSTEMIC THERAPY;
TREATMENT OUTCOME;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
DRUG COMBINATION;
FEMALE;
KIDNEY TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
DRUG THERAPY, COMBINATION;
FEMALE;
GERMANY;
HUMANS;
INTERFERON-ALPHA;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
|
EID: 0038009266
PISSN: 03402592
EISSN: None
Source Type: Journal
DOI: 10.1007/s00120-002-0205-3 Document Type: Review |
Times cited : (5)
|
References (1)
|